<DOC>
	<DOC>NCT01126034</DOC>
	<brief_summary>The investigators hypothesized that: 1) an intervention targeted at the prescribing physician would increase the rate of a metoclopramide discontinuation among patients prescribed the medication for questionable or unclear indications; and 2) the discontinuation would be durable.</brief_summary>
	<brief_title>Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<criteria>Physicians at University of Pennsylvania Health System who ordered an active metoclopramide prescription with a questionable indication. Physiciansintraining (e.g., residents, fellows) Physicians how were investigators on this study Physicians serving on the the University of Pennsylvania Drug Use and Effects Committee or Information Technology Oversight Board</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Metoclopramide</keyword>
	<keyword>Randomized Controlled Trial</keyword>
</DOC>